Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Antaros Medical (Sweden)
Homepage:
antarosmedical.com
ROR:
029v5hv47
OpenAlex ID:
I4210115315
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
2018
·
Jan W. Eriksson
, Per Lundkvist
, et al.
·
Diabetologia
·
395
PDF
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
2024
·
Michele Vacca
, Ioannis Kamzolas
, et al.
·
Nature Metabolism
·
255
PDF
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
2019
·
Aino Latva-Rasku
, Miikka-Juhani Honka
, et al.
·
Diabetes Care
·
252
Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial
2019
·
Fredrik Rosqvist
, Joel Kullberg
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
237
PDF
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging
2021
·
Anne Flint
, Grit Andersen
, et al.
·
Alimentary Pharmacology & Therapeutics
·
221
PDF
Transplantation of macroencapsulated human islets within the bioartificial pancreas βAir to patients with type 1 diabetes mellitus
2017
·
Per-Ola Carlsson
, Daniel Espes
, et al.
·
American Journal of Transplantation
·
205
PDF
Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
2021
·
Martin Bossart
, Michael Wagner
, et al.
·
Cell Metabolism
·
178
PDF
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
2023
·
Ruben Smith
, Francesca Capotosti
, et al.
·
Nature Communications
·
155
PDF
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA
2018
·
Nicholas M Selby
, Peter J Blankestijn
, et al.
·
Nephrology Dialysis Transplantation
·
149
PDF
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
2018
·
Jan Oscarsson
, Kristina Önnerhag
, et al.
·
Journal of clinical lipidology
·
112
PDF
Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI
2019
·
Ilona A. Dekkers
, Anneloes de Boer
, et al.
·
Magnetic Resonance Materials in Physics Biology and Medicine
·
111
PDF
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
2022
·
Rohit Loomba
, Eric J Lawitz
, et al.
·
The Lancet. Gastroenterology & hepatology
·
105
Automated analysis of liver fat, muscle and adipose tissue distribution from CT suitable for large-scale studies
2017
·
Joel Kullberg
, Anders Hedström
, et al.
·
Scientific Reports
·
89
PDF
A 6‐month randomized, double‐blind, placebo‐controlled trial of weekly exenatide in adolescents with obesity
2020
·
D. Weghuber
, A. Forslund
, et al.
·
Pediatric Obesity
·
78
PDF
The effect of ticagrelor on growth of small abdominal aortic aneurysms—a randomized controlled trial
2019
·
Anders Wanhainen
, Kevin Mani
, et al.
·
Cardiovascular Research
·
70
Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo‐controlled, exploratory study
2021
·
Jonas Oldgren
, Sanna Laurila
, et al.
·
Diabetes Obesity and Metabolism
·
61
Altered Glucose Uptake in Muscle, Visceral Adipose Tissue, and Brain Predict Whole-Body Insulin Resistance and may Contribute to the Development of Type 2 Diabetes: A Combined PET/MR Study
2018
·
Gretha Boersma
, Emil Johansson
, et al.
·
Hormone and Metabolic Research
·
60
Automatic segmentation of large-scale CT image datasets for detailed body composition analysis
2023
·
Nouman Ahmad
, Robin Strand
, et al.
·
BMC Bioinformatics
·
59
PDF
Fully convolutional networks for automated segmentation of abdominal adipose tissue depots in multicenter water–fat MRI
2018
·
Taro Langner
, Anders Hedström
, et al.
·
Magnetic Resonance in Medicine
·
57
PDF
Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials
2020
·
Carine Beysen
, Patricia Schroeder
, et al.
·
Diabetes Obesity and Metabolism
·
54
PDF
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
2023
·
Victoria E. R. Parker
, Darren Robertson
, et al.
·
Nature Metabolism
·
52
PDF
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
2023
·
Patrick Veit-Haibach
, Håkan Ahlström
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
51
PDF
A concept for holistic whole body MRI data analysis, Imiomics
2017
·
Robin Strand
, Filip Malmberg
, et al.
·
PLoS ONE
·
47
PDF
Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes
2020
·
Olof Eriksson
, Torsten Haack
, et al.
·
Scientific Reports
·
46
PDF
Separation of water and fat signal in whole‐body gradient echo scans using convolutional neural networks
2019
·
Jonathan Andersson
, Håkan Ahlström
, et al.
·
Magnetic Resonance in Medicine
·
44
PDF
Show more works
View as search
Works count:
307
Citation count:
10,770
Year
Topic
Type
